Roger Stupp, MD
Northwestern University · Centre Hospitalier Universitaire Vaudois · University Hospital, Zürich
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Roger Stupp, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:56 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06169280 · Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade GliomaNorthwestern University · active not recruiting · Glioma, Malignant, New Diagnosis Tumor · principal investigator
- Ph1NCT06137651 · Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal MetastasisNorthwestern University · withdrawn · Breast Carcinoma, Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Neoplasm in the Leptomeninges · principal investigator
- Ph2NCT05864534 · Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed GlioblastomaNorthwestern University · active not recruiting · Newly Diagnosed Glioblastoma, Glioblastoma, Isocitric Dehydrogenase (IDH)-Wildtype, Gliosarcoma · study director
- Ph1/Ph2NCT04528680 · Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent GlioblastomaNorthwestern University · active not recruiting · Glioblastoma, Gliosarcoma, GBM · study chair
- Ph2NCT01059188 · Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)Swiss Cancer Institute · completed · Lung Cancer · study chair
- Ph3NCT00916409 · Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)NovoCure Ltd. · completed · Glioblastoma Multiforme · study director
- Ph2NCT00424060 · Epothilone ZK-219477 in Treating Patients With Recurrent GlioblastomaEuropean Organisation for Research and Treatment of Cancer - EORTC · completed · Brain and Central Nervous System Tumors · study chair
- Ph3NCT00379470 · Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)NovoCure Ltd. · completed · Recurrent Glioblastoma Multiforme · principal investigator
- Ph3NCT00304031 · Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or GliosarcomaRadiation Therapy Oncology Group · completed · Brain and Central Nervous System Tumors · study chair
- Ph2NCT00238251 · Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain MetastasesSwiss Cancer Institute · completed · Lung Cancer, Metastatic Cancer · principal investigator
- Ph3NCT00182819 · Radiation Therapy or Temozolomide in Treating Patients With GliomasEuropean Organisation for Research and Treatment of Cancer - EORTC · completed · Brain and Central Nervous System Tumors · study chair
- Ph3NCT00006353 · Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeEuropean Organisation for Research and Treatment of Cancer - EORTC · completed · Brain and Central Nervous System Tumors · study chair
- Ph2NCT00030810 · Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLCSwiss Cancer Institute · completed · Lung Cancer · study chair
- Ph3NCT00030771 · Preoperative Chemoradiotherapy vs. Chemotherapy Alone in NSCLC PatientsSwiss Cancer Institute · completed · Lung Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Cancer Center AdministrationP30CA060553 · NCI · NORTHWESTERN UNIVERSITY · PI Aleksandar Zafirovski · fiscal years 2012 to 2026Named on NCT06137651
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in glioblastoma.